Literature DB >> 10476780

Effects of hyaluronan lyase, hyaluronidase, and chondroitin ABC lyase on mammalian vitreous gel.

P N Bishop1, D McLeod, A Reardon.   

Abstract

PURPOSE: To determine the effects of enzymes on mammalian vitreous gel and to thus infer the structural roles of hyaluronan and chondroitin sulfate in the gel.
METHODS: The wet weights of bovine vitreous gels were compared before and after incubation with Streptomyces hyaluronan lyase, chondroitin ABC lyase, testicular hyaluronidase, or buffer alone. The extent of hyaluronan depolymerization was determined by chromatography and that of chondroitin sulfate depolymerization by western blot analysis.
RESULTS: After digestion with Streptomyces hyaluronan lyase (30 U/gel), the gel wet weight was the same as that of controls (incubated with buffer alone) despite 94% of the hyaluronan having been depolymerized; when digested with 100 U/gel, the gel wet weight decreased (to 57% of original wet weight versus 86% for controls, P = < 0.001) and hyaluronan was completely depolymerized. Chondroitin ABC lyase digestion (0.2 U/gel) resulted in a slight reduction in gel wet weight (90% versus 96%, P = < 0.001) and depolymerization of 88% of the hyaluronan; the presence of fully digested chondroitin sulfate chains was established. Digestions with 100 and 500 U/gel of testicular hyaluronidase resulted in a decrease (P = < 0.001, both cases) in gel wet weight (53% versus 82%, 100 U/gel; 57%, versus 86%, 500 U/gel) with 75% and 97% hyaluronan depolymerization, respectively.
CONCLUSIONS: Depolymerization of all vitreous hyaluronan and of chondroitin sulfate resulted in gel wet weight reduction but not gel destruction. Digestion with 30 U/gel of Streptomyces hyaluronan lyase revealed a small pool (6%) of relatively enzyme-resistant hyaluronan that specifically contributed toward maintaining gel wet weight.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10476780

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Molecular biology of pharmacologic vitreolysis.

Authors:  J Sebag
Journal:  Trans Am Ophthalmol Soc       Date:  2005

2.  Preservation of the structure of enzymatically-degraded bovine vitreous using synthetic proteoglycan mimics.

Authors:  Qianru Zhang; Benjamen A Filas; Robyn Roth; John Heuser; Nan Ma; Shaili Sharma; Alyssa Panitch; David C Beebe; Ying-Bo Shui
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-23       Impact factor: 4.799

3.  Relevance of synovial fluid chondroitin sulphate as a biomarker to monitor polo pony joints.

Authors:  Raquel Y A Baccarin; Luciane Rasera; Thaís S L Machado; Yara M Michelacci
Journal:  Can J Vet Res       Date:  2014-01       Impact factor: 1.310

4.  Efficacy of plasmin enzymes and chondroitinase ABC in creating posterior vitreous separation in the pig: a masked, placebo-controlled in vivo study.

Authors:  Martin Hermel; Norbert F Schrage
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-10       Impact factor: 3.117

Review 5.  Structure and mechanics of the vitreoretinal interface.

Authors:  Joseph D Phillips; Eileen S Hwang; Denise J Morgan; Christopher J Creveling; Brittany Coats
Journal:  J Mech Behav Biomed Mater       Date:  2022-08-05

6.  Effect of intravitreal plasmin on vitreous removal through a 25-gauge cutting system in the rabbit in vivo.

Authors:  Martin Hermel; Jonathan Prenner; Motaz Alabdulrazzak; Wendy Dailey; Michael Hartzer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-26       Impact factor: 3.117

Review 7.  Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease.

Authors:  J Sebag
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08       Impact factor: 3.117

8.  Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review.

Authors:  Eric W Schneider; Mark W Johnson
Journal:  Clin Ophthalmol       Date:  2011-08-18

Review 9.  Ocriplasmin: who is the best candidate?

Authors:  Claudia M Prospero Ponce; William Stevenson; Rachel Gelman; Daniel R Agarwal; John B Christoforidis
Journal:  Clin Ophthalmol       Date:  2016-03-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.